TrademarkDir
DISEASEMETRICS
DEAD

Serial Number

76000391

Owner

PHARMETRICS, INC.

Attorney

Michael J. Bevilacqua, Esquire

Filing Date

Mar 14, 2000

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DISEASEMETRICS Trademark

Serial Number: 76000391

DISEASEMETRICS is a trademark filed by PHARMETRICS, INC. on March 14, 2000. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PHARMETRICS, INC. (26 trademarks)

150 Coolidge Avenue
Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

March 14, 2000

Registration Date

Not Registered

Published for Opposition

November 7, 2000

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 10, 2007 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2005 TCCA
ABANDONMENT - NO USE STATEMENT FILED
Mar 17, 2004 ABN6
SOU EXTENSION 5 GRANTED
Jul 9, 2003 EX5G
SOU EXTENSION 5 FILED
Jul 2, 2003 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 1, 2003 EEXT
SOU EXTENSION 4 GRANTED
Mar 31, 2003 EX4G
SOU EXTENSION 4 FILED
Jan 23, 2003 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 23, 2003 EEXT
SOU EXTENSION 3 GRANTED
Jul 30, 2002 EX3G
SOU EXTENSION 3 FILED
Jul 30, 2002 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 30, 2002 EEXT
SOU EXTENSION 2 GRANTED
Feb 27, 2002 EX2G
SOU EXTENSION 2 FILED
Jan 18, 2002 EXT2
SOU EXTENSION 1 GRANTED
Jul 18, 2001 EX1G
SOU EXTENSION 1 FILED
Jun 22, 2001 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 30, 2001 NOAM
PUBLISHED FOR OPPOSITION
Nov 7, 2000 PUBO
NOTICE OF PUBLICATION
Oct 6, 2000 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2000 CNSA
ASSIGNED TO EXAMINER
Aug 25, 2000 DOCK
ASSIGNED TO EXAMINER
Aug 21, 2000 DOCK

Related Trademarks

More from this Owner

TIMELY, ACCURATE, ACTIONABLE

TIMELY, ACCURATE, ACTIONABLE

TIMELY, ACCURATE, ACTIONABLE

TIMELY, ACCURATE, ACTIONABLE

TIMELY, ACCURATE, ACTIONABLE

TIMELY, ACCURATE, ACTIONABLE

TIMELY, ACCURATE, ACTIONABLE

TIMELY, ACCURATE, ACTIONABLE

DECISIONMETRICS

DECISIONMETRICS

TREATMENT PROFILER

TREATMENT PROFILER